Published on 1 Mar 2024 on Simply Wall St. via Yahoo Finance
With 62% ownership, Avadel Pharmaceuticals plc (NASDAQ:AVDL) boasts of strong institutional backing
Key Insights
Given the large stake in the stock by institutions, Avadel Pharmaceuticals' stock price might be vulnerable to their trading decisionsA total of 5 investors have a majority stake in the company with 51% ownership Insiders have been selling lately
If you want to know who really controls Avadel Pharmaceuticals plc (NASDAQ:AVDL), then you'll have to look at the makeup of its share registry. With 62% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).